Organization
Vaxine
6 clinical trials
Clinical trial
A Phase I Trial of Autologous Tumour Vaccine for Advanced Solid CancersStatus: Recruiting, Estimated PCD: 2026-02-10
Clinical trial
A Binded, Randomised, Controlled Cross-over Trial to Assess the Safety and Efficacy of Mucosal Covid-19 and Influenza VaccinesStatus: Not yet recruiting, Estimated PCD: 2024-04-21
Clinical trial
A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus InfectionStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Phase 2b Study to Assess the Effect of Dose Interval on the Effectiveness of a Protein-based Covid-19 Vaccine (Spikogen® Vaccine)Status: Active (not recruiting), Estimated PCD: 2023-02-23
Clinical trial
A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)Status: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
Immunogenicity and Safety Study in Ambulatory Adults of a Single Intramuscular Dose of SpikoGen Vaccine as a Heterologous or Homologous Booster Dose Following Completion of a Primary Course of Covid-19 VaccineStatus: Active (not recruiting), Estimated PCD: 2023-12-31